We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Colon Cancer in Pyogenic Liver Abscess

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02032914
First Posted: January 10, 2014
Last Update Posted: March 1, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Pusan National University Yangsan Hospital
Information provided by (Responsible Party):
Tae Oh Kim, Inje University
  Purpose
Although a proportion of pyogenic liver abscess may originated from colonic mucosal lesions, the prevalence of colonic neoplasm in the patients with pyogenic liver abscess are still not evaluated yet. Thus, our group will find the prevalence of colonic neoplasm in the group of cryptogenic pyogenic liver abscess by colonoscopic examination.

Condition Phase
Cryptogenic Pyogenic Liver Abscess Phase 4

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 3 Months
Official Title: The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess

Resource links provided by NLM:


Further study details as provided by Tae Oh Kim, Inje University:

Primary Outcome Measures:
  • The prevalence of colonic neoplasm [ Time Frame: within 6 weeks after diagnosis of pyogenic liver abscess ]

Secondary Outcome Measures:
  • Prevalence of colon polyp [ Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess ]
  • Prevalence of colonic diverticulitis [ Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess ]
  • Prevalence of inflammatory bowel disease [ Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess ]
  • Prevalence of intestinal tuberculosis [ Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess ]

Enrollment: 62
Study Start Date: January 2014
Study Completion Date: February 2016
Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts
Colonoscopic examination group
The patients diagnosed with cryptogenic pyogenic liver abscess

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The patients diagnosed as pyogenic liver abscess, the cause of which is not found at initial evaluation
Criteria

Inclusion Criteria:

  • Pyogenic liver abscess radiologically and bacteriologically diagnosed

Exclusion Criteria:

  • Amebic liver abscess
  • Other causes of pyogenic liver abscess such as cholangitis, liver cancer, complication of transarterial chemoembolization or radiofrequency ablation to hepatocellular carcinoma
  • Refusal to colonoscopic examination
  • Inadequate general patient status to perform the colonoscopic examination
  • Patient who has had the screening colonoscopic examination within 1 year and showed normal finding or had 1 or 2 colon polyp in adequate exam
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02032914


Locations
Korea, Republic of
Pusan National Unversity Yangsan Hospital
Yangsan-si, Gyeongsangnam-do, Korea, Republic of
Inje University Haeundae Paik Hospital
Busan, Korea, Republic of
Sponsors and Collaborators
Inje University
Pusan National University Yangsan Hospital
Investigators
Principal Investigator: Tae Oh Kim, M.D. Inje University Haeundae Paik Hosptial
  More Information

Responsible Party: Tae Oh Kim, Assistant professor, Inje University
ClinicalTrials.gov Identifier: NCT02032914     History of Changes
Other Study ID Numbers: 1
First Submitted: January 8, 2014
First Posted: January 10, 2014
Last Update Posted: March 1, 2016
Last Verified: February 2016

Keywords provided by Tae Oh Kim, Inje University:
pyogenic liver abscess
colon cancer

Additional relevant MeSH terms:
Abscess
Liver Abscess
Liver Abscess, Pyogenic
Suppuration
Infection
Inflammation
Pathologic Processes
Abdominal Abscess
Liver Diseases
Digestive System Diseases